Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Cash Flow Reinvestment Rate
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Cash Flow Reinvestment Rate of 0.49x as of September 2025, reinvesting CN¥38.83 Million (capex CN¥38.83 Million ) from operating cash flow of CN¥79.81 Million. Explore how much does Shandong Jincheng Pharmaceutical and Che reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Also explore how large is Shandong Jincheng Pharmaceutical and Che's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For live market cap and broader valuation context, see Shandong Jincheng Pharmaceutical and Che market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.32x | CN¥102.08 Million | CN¥319.64 Million | CN¥100.88 Million | ▼ -35.3% |
| 2024 | 0.49x | CN¥146.29 Million | CN¥296.59 Million | CN¥142.61 Million | ▼ -5.2% |
| 2023 | 0.52x | CN¥345.61 Million | CN¥664.08 Million | CN¥342.90 Million | ▼ -81.8% |
| 2022 | 2.86x | CN¥731.49 Million | CN¥255.63 Million | CN¥373.67 Million | ▲ +147.6% |
| 2021 | 1.16x | CN¥505.25 Million | CN¥437.19 Million | CN¥376.14 Million | ▲ +44.0% |
| 2020 | 0.80x | CN¥438.44 Million | CN¥546.13 Million | CN¥272.44 Million | ▲ +22.3% |
| 2019 | 0.66x | CN¥379.29 Million | CN¥577.98 Million | CN¥361.65 Million | ▼ -43.2% |
| 2018 | 1.16x | CN¥406.96 Million | CN¥352.20 Million | CN¥349.88 Million | ▼ -11.2% |
| 2017 | 1.30x | CN¥197.63 Million | CN¥151.83 Million | CN¥193.80 Million | ▲ +50.5% |
| 2016 | 0.87x | CN¥208.89 Million | CN¥241.48 Million | CN¥158.89 Million | ▲ +10.8% |
| 2015 | 0.78x | CN¥162.35 Million | CN¥207.92 Million | CN¥159.85 Million | ▲ +7.4% |
| 2014 | 0.73x | CN¥159.57 Million | CN¥219.46 Million | CN¥159.57 Million | ▼ -57.4% |
| 2013 | 1.71x | CN¥160.18 Million | CN¥93.92 Million | CN¥160.18 Million | ▲ +35.2% |
| 2012 | 1.26x | CN¥109.21 Million | CN¥86.61 Million | CN¥109.21 Million | ▼ -41.4% |
| 2011 | 2.15x | CN¥135.00 Million | CN¥62.69 Million | CN¥135.00 Million | ▲ +73.6% |
| 2010 | 1.24x | CN¥134.78 Million | CN¥108.67 Million | CN¥134.78 Million | ▲ +41.5% |
| 2009 | 0.88x | CN¥92.58 Million | CN¥105.62 Million | CN¥92.58 Million | ▼ -49.9% |
| 2008 | 1.75x | CN¥52.87 Million | CN¥30.23 Million | CN¥52.87 Million | — |